Moreover, we demonstrated that FGF23 contributes to pathologic cardiac remodeling and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts resulting in enhanced cardiac hypertrophy and fibrosis in the absence of klotho (30). The gene discussed is KL; the disease is cardiac hypertrophy.